Latest Breaking News On - Strasburg pharms - Page 1 : comparemela.com
CDB Global Announces Change of Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
CBD Global Sciences Debt Restructuring and Impact of both Global NV and Strasburg Pharms Bankruptcies, Post Bankruptcy Action Plans
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
CBD Global Sciences Debt Restructuring and Impact of both Global NV and Strasburg Pharms
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
CBD Global Announces Delayed Filing of Annual Financial Statements and MD&A and Application for Management Cease Trade Order
CBD Global SciecnesApril 14, 2021 GMT
CBD Global Sciecnes
CBD Global Sciecnes
Denver, Colorado - ( NewMediaWire ) - April 14, 2021 - CBD Global Sciences Inc. (CSE: CBDN) (the “Company”) would like to provide an update on the status of the filing of its annual financial statements, accompanying management’s discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2020 (collectively, the “Annual Filings”).
Due to the continued impact of COVID-19, and the logistical complications for its auditor to conduct the audit of certain operations, the Company anticipates the Annual Filings will be delayed beyond the required filing deadline: (i) under Parts 4 and 5 of National Instrument 51-102 – Continuous Disclosure Oblig